Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013–2017): a prospective cohort study

by Jørn Henrik Vold, Svetlana Skurtveit, Christer Aas, Kjell Arne Johansson, Lars Thore Fadnes
Published 2020-07-01

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017

by Jørn Henrik Vold, Svetlana Skurtveit, Christer Aas, Fatemeh Chalabianloo, Pia Synnøve Kloster, Kjell Arne Johansson, Lars Thore Fadnes
Published 2020-04-01

Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to...

by Jørn Henrik Vold, Christer Aas, Svetlana Skurtveit, Ingvild Odsbu, Fatemeh Chalabianloo, Anne Halmøy, Kjell Arne Johansson, Lars Thore Fadnes
Published 2020-03-01

Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017

by Ingvild Odsbu, Kjell Arne Johansson, Jørn Henrik Vold, Christer Aas, Fatemeh Chalabianloo, Johan Reutfors, Anne Halmøy, Lars Thore Fadnes
Published 2020-08-01

Integrated care of severe infectious diseases to people with substance use disorders; a systematic review

by Jørn Henrik Vold, Christer Aas, Rafael Alexander Leiva, Peter Vickerman, Fatemeh Chalabianloo, Else-Marie Løberg, Kjell Arne Johansson, Lars Thore Fadnes
Published 2019-04-01

Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway

by Fatemeh Chalabianloo, Lars Thore Fadnes, Gudrun Høiseth, Christian Ohldieck, Jørn Henrik Vold, Christer Aas, Else-Marie Løberg, Kjell Arne Johansson, Jørgen G. Bramness
Published 2021-05-01